Clinical Trials Browser

Phase 4 × Recruiting × Dermatologic × Clear all

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07504796 2026-04-21

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

Phase 4 Recruiting

90 enrolled

Dermatologic

Melanoma

NCT03340506 2026-04-20

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

100 enrolled

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT07200544 2025-12-15

Meloxicam in Mohs Micrographic Surgery

Phase 4 Recruiting

300 enrolled

Dermatologic

Pain, Postoperative, Skin Neoplasms

NCT06499415 2025-05-11

CALM

Phase 4 Recruiting

232 enrolled

Dermatologic

Keratosis, Actinic

NCT06627036 2025-01-24

ClearMark

Phase 4 Recruiting

1,376 enrolled

Dermatologic

Skin Neoplasms

NCT06647342 2025-01-23

BLESS

Phase 4 Recruiting

55 enrolled

Dermatologic

Skin Neoplasms